FDA Commissioner Marty Makary said today at the Food and Drug Law Institute’s annual conference: “We want to create a framework for vaccine makers that they can use so they have a predictable FDA where they don’t have to worry how is this going to be received.” The FDA is preparing to release a framework in the coming weeks that will share the agency’s thinking on its oversight of vaccines, Makary explained. Companies who make vaccines include Pfizer (PFE), BioNTech (BNTX), and Moderna (MRNA), GSK (GSK), Novavax (NVAX) and Vaxcyte (PCVX).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Lawmakers investigating allegations on timing of Pfizer COVID vaccine, WSJ says
- Mixed options sentiment in Pfizer (PFE), with shares up $0.33 (+1.48%) near $22.34
- Pfizer’s Hold Rating: Balancing Policy Uncertainties and Long-Term Growth Prospects
- U.S. biotech companies debate relocating trials outside U.S., Reuters reports
- Terns Pharmaceuticals price target lowered to $15 from $26 at BMO Capital